CollPlant Biotechnologies Ltd Capital Expenditures
CollPlant Biotechnologies Ltd (CLGN) reported Capital Expenditures of $28.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-26
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|
| 2025-12-31 | $28.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $12.00K 6-K · filed 2025-08-20 | |
| 2024-12-31 | $483.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $284.00K 6-K · filed 2025-08-20 | |
| 2023-12-31 | $954.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | $482.00K 6-K · filed 2024-08-20 | |
| 2022-12-31 | $1.27M 20-F · filed 2025-03-26 | |
| 2022-06-30 | $678.00K 6-K · filed 2023-08-24 | |
| 2021-12-31 | $1.43M 20-F · filed 2024-04-04 | |
| 2021-06-30 | $365.00K 6-K · filed 2022-08-25 | |
| 2020-12-31 | $437.00K 20-F · filed 2023-03-29 | |
| 2020-06-30 | $246.00K 6-K · filed 2021-08-19 | |
| 2019-12-31 | $1.49M 20-F · filed 2022-03-24 | |
| 2019-06-30 | $1.06M 6-K · filed 2020-08-28 | |
| 2018-12-31 | $832.00K 20-F · filed 2021-03-26 |